Crohn's Disease and Colitis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are willing and have agreed to participate by signing a consent form
- You are male or female and are 18 years old or older
- You started treatment with a medication called Ustekinumab between February 2019 and March 2021, for an approved medical reason and as part of normal clinical care
Who may not be able to join:
- There are no specific exclusion criteria listed for this trial
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Paolo Gionchetti, MD, IRCCS Azienda Ospedaliero-Universitaria di Bologna
Phone: +39 0512145312
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Overall persistence of patients with Crohn's Disease and Ulcerative Colitis who started Ustekinumab.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.